Response to Patent Owner's Discretionary Denial Brief | Mar 4, 2026 | PAPER | PETITIONER |
Ex. 1041 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1042 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1043 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1044 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1045 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1046 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1047 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1048 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1049 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1050 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1051 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1052 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1053 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1054 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1055 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1056 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1057 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Ex. 1058 | Mar 4, 2026 | EXHIBIT | PETITIONER |
Patent Owner's Preliminary Response | Mar 4, 2026 | PAPER | PATENT OWNER |
Declaration of John A. McLean, Ph.D. | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of John A. McLean, Ph.D. | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Wörner and Heck et al., “Adeno-associated virus capsid assembly is divergent and stochastic,” | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Kontogiannis et al., “Characterization of AAV vectors: A review of analytical techniques and critical quality attributes,” | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Salganik et al., “Evidence for pH-Dependent Protease Activity in the Adeno-Associated Virus Capsid,” | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Supplemental Materials to Ansong et al., “Top-down proteomics reveals a unique protein S-thiolation switch in Salmonella Typhimurium in response to infection-like conditions,” | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Lancaster and Ha et al., “Characterization of N-glycosylation profiles from mammalian and insect derived chikungunya VLP,” | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
ICH Harmonised Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology Q2(R1) | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Boys et al., “Protein Oxidative Modifications During Electrospray Ionization: Solution Phase Electrochemistry or Corona Discharge-Induced Radical Attack?,” | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Knolhoff, Callahan, and Croley, “Mass Accuracy and Isotopic Abundance Measurements for HR-MS Instrumentation: Capabilities for Non-Targeted Analyses,” | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Valeja et al., “Three Dimensional Liquid Chromatography Coupling IEC/HIC/RPC for Effective Protein Separation in Top-Down Proteomics,” | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Han, Aslanian, & Yates, “Mass spectrometry for proteomics,” | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
May & McLean, “Advanced Multidimensional Separations in Mass Spectrometry: Navigating the Big Data Deluge,” | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Wright & Wright, “Advances in LC: Bioanalytical Method Transfer,” | Mar 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 78 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 59 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 68 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 28 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 35 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 37 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 45 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 67 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 83 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 87 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 91 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 92 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 99 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 102 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 110 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 76 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) - Defendant’s Supplemental Initial Invalidity Contentions | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
US Patent 11,698,377 | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
US Patent 11,698,377 File History | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Vliet | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Bark | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Genzyme Corporation v. Sarepta Therapeutics Inc. Joint Claim Construction Chart | Feb 4, 2026 | EXHIBIT | PATENT OWNER |
Patent Owner's Request for Discretionary Denial | Feb 4, 2026 | PAPER | PATENT OWNER |
Patent Owner's Updated Mandatory Notices | Jan 20, 2026 | PAPER | PATENT OWNER |
Petitioner's Sotera Stipulation | Dec 30, 2025 | PAPER | PETITIONER |
Notice of Intent to Designate Katherine Helm as Back-Up Counsel | Dec 29, 2025 | PAPER | PATENT OWNER |
Declaration of Katherine Helm | Dec 29, 2025 | EXHIBIT | PATENT OWNER |
Notice: Power of Attorney | Dec 23, 2025 | PAPER | PATENT OWNER |
Notice: Mandatory Notice | Dec 23, 2025 | PAPER | PATENT OWNER |
Notice: Notice filing date accorded | Dec 4, 2025 | PAPER | BOARD |
Ex. 1001 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1002 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1004 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1005 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1006 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1007 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1008 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1009 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1010 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1011 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1012 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1013 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1014 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1015 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1016 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1017 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1018 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1019 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1020 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1021 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1022 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1023 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1024 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1025 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1026 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1027 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1028 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1029 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1030 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1031 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1032 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1033 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1034 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1035 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1036 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1037 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1038 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1039 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Ex. 1040 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Notice: Power of Attorney | Dec 2, 2025 | PAPER | PETITIONER |
Ex. 1003 | Dec 2, 2025 | EXHIBIT | PETITIONER |
Petition: as filed | Dec 2, 2025 | PAPER | PETITIONER |